Research on IP Group plc (IPO:LON) from Equity Development
Chair appointment: IP Group has appointed Michael Queen (ex‑CEO of 3i) as Chair Designate, succeeding Sir Douglas Flint on 18 June 2026, adding deep private‑equity, venture and policy experience. NAV vs share price: Group NAV at 31 Dec 2025 was 110p per share; the 64p share price implies the unquoted portfolio is valued at 42p, a 52% discount to its 88p NAV. Exits momentum: Portfolio companies are maturing, with £183m realised in 2024, £68m in 2025, and c.£180m targeted by end‑2027, providing near‑term validation potential. Upside optionality: Further NAV upside could come from royalty income tied to Pfizer’s next‑gen obesity drugs (subject to approvals); successful exits and/or approvals could narrow an arguably irrational discount.
View Full Research

